Market Chatter: EQT Reportedly in Late-stage Talks to Acquire Qiagen for Over $50 Per Share

MT Newswires · 1d ago
11:26 PM EDT, 10/20/2026 (MT Newswires) -- Swedish private equity firm EQT (EQT.ST) is advancing negotiations to acquire Qiagen (QIA.F) after submitting a binding offer of more than $50 per share, Bloomberg News reported Tuesday, citing sources familiar with the matter. Rival equity firm KKR has also submitted a bid for the molecular testing company, the people said. Qiagen's board will reportedly meet this week to consider a potential deal, although a sale is not guaranteed. Qiagen declined to comment, while EQT and KKR did not immediately respond to requests for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)